Supply chain constraints plague current neglected tropical disease (NTD) prevention and treatment programs. The rapid expansion of NTD control activities has not been without pharmaceutical and health system challenges. Inadequate NTD drug management in many countries has resulted in excess stocks, leading to waste resulting from drug expiry or stock-outs, leading to treatment interruption. SIAPS has received funding from USAID to support the Senegal MoH in strengthening the systems for NTD pharmaceutical management. The purpose of the technical assistance is to undertake a rapid assessment of the NTD pharmaceutical management system and understand the integration efforts. Technical review and recommendations have been provided by SIAPS personnel based in the SIAPS West Africa Offices and the office in Arlington, Virginia. SIAPS held meetings with the MoH NTD focal points and supply chain managers to ensure efficient delivery of technical support to the NTD programs, cross fertilization, sharing of lessons learned, challenges, and recommendations and to ensure that the implemented interventions are of the highest technical quality that focuses on country objectives.
Manuel de procédures de gestion des achats et des stocks des produits de santé de lutte contre le VIH/SIDA
Ce manuel de procédures de Gestion des Achats et des Stocks (GAS) des produits de lutte contre le VIH/Sida vise à décrire d’une manière synthétique les procédures à suivre par le GTC-CNLS, la Centrale Nationale d’Approvisionnement en Médicaments et consommables médicaux Essentiels (CENAME), les Centres d’Approvisionnement Pharmaceutique Régionaux (CAPR) et les Formations Sanitaires (FOSA) lors des activités liées à la gestion des achats et des stocks des produits de santé de lutte contre le VIH/Sida acquis dans le cadre de la subvention de la série 10 du Fonds mondial de Lutte contre le VIH/SIDA, la Tuberculose et le Paludisme.
Guidelines for Redistribution of Excess and Near-Expiry Essential Medicines between Public Health Facilities in South Sudan
The increased shortages and stock-out of essential medicines have raised the need to understand the causes of medicine expiries and subsequently develop strategies for their prevention and management.The MOH has developed this document to empower health workers at all levels to redistribute medicines and supplies that are not needed or are about to expire. Therefore, the procedures presented in this document should be used as a guideline to manage and execute the redistribution of essential medicines by technical staff and health managers at health facilities and program levels.
Closing the Financial Gap to Ensure Availability of HIV and AIDS Commodities in the Dominican Republic
SIAPS’ predecessor project, Strengthening Pharmaceutical Systems, worked with the government to establish the SUGEMI system to provide more accurate information on consumption, forecasting, pricing, and distribution. SUGEMI is an information system that is fully aligned with the country’s health sector reform process, compatible with the decentralized health sector, and designed to coordinate information across different vertical disease programs. These features were essential to promote the long-term sustainability and local ownership of the system.
Medicine prices are a contentious issue, with many products arguably unaffordable, even in developed countries, where, on average, approximately 10% of the health budget is spent on medicines. But in low- and middle-income countries, that figure is usually substantially higher, reflecting both limited resources and generally inefficient public health systems. Given that a sizable proportion of the population usually pays for medicines out of pocket, high medicine costs disproportionally affect the economically disadvantaged and are more likely to impair patient access to effective treatments in poorer communities.
The final price for the paying customer—whether the patient, the public health service, or an insurance company— is compounded by all activities involved in the development, production, procurement, and distribution of the medicine. This report will focus on only those activities that are under the control of the Government of Ukraine, that is, procurement and distribution. However, it is worth mentioning that development and production costs—activities that are undertaken by private companies and that are often used to justify high prices—are currently under international scrutiny, with recent studies showing that pharmaceutical companies spend more on marketing than on research and development.
The US Agency for International Development (USAID)-funded program, Systems for Improved Access to Pharmaceuticals and Services (SIAPS), implemented by Management Sciences for Health (MSH), has been providing technical assistance to the Angola Ministry of Health (MOH) to improve pharmaceutical management since 2011. An analysis of the Angolan public health supply chain system conducted in November/December 2012 found that the Central Procurement Agency for Medicines and Medical Supplies (Central de Compras de Medicamentos e Meios Medicos de Angola—CECOMA) needed to improve its warehouse management processes, update its procedures, review and improve its human resource capacity development strategies as well as develop and implement key performance indicators (KPI). The resulting report included short- and long-term recommendations and a high-level implementation plan.
The purpose of this activity was to design and implement warehouse operations system improvements for CECOMA, and to design and implement a human resource capability development and performance improvement (HRCD&PI) program based on the identified gaps.
Le Gouvernement de la République du Mali a fait de la Pharmacie Populaire du Mali (PPM) un outil privilégié de l’exécution de sa politique nationale pharmaceutique en matière d’approvisionnement, de stockage et de distribution des médicaments essentiels, et dans ce cadre des engagements ont été pris par les parties prenantes, à travers un cadre juridique : le Contrat-plan entre l’État et la PPM. Pour une meilleure mise en œuvre du Contrat-plan, la PPM a élaboré un plan stratégique de cinq ans (2015 à 2019) dont la performance sera régulièrement évaluée, à travers les résultats obtenus dans la mise en œuvre de plans d’action annuels. Ce document est le tout premier plan stratégique de la PPM ; il a capitalisé ses acquis et arrivera à bout de ses défis pour exceller dans l’acquisition, le stockage et la distribution des médicaments essentiels, des dispositifs médicaux et des réactifs, à travers la pyramide sanitaire, à des coûts abordables.
Warehouse Improvement Plan and Draft Operating Procedures for the Central Warehouses of the Directorate General of Health Services and the Directorate General of Family Planning in Bangladesh
This report summarizes technical findings and recommendations to assist two important supply chain management organizations that support the Government of Bangladesh’s (GOB) Ministry of Health and Family Welfare (MOHFW). The first organization— the Ministry’s Central Medical Stores Depot (CMSD)—is headquartered in Dhaka. It serves as the central procurement and distribution arm of the Directorate General of Health Services (DGHS). The second organization—the central warehouse (CWH) of the Directorate General of Family Planning (DGFP)—is also located in Dhaka. It supports the DGFP’s family planning and reproductive health commodity storage and distribution requirements.
This report estimates the cost of the Kenyan and Beninese distribution networks for artemisininbased combination therapies (ACTs) and rapid diagnostic tests (RDTs) in the public sector. Based on this work, we created an extrapolative model to allow donors and country budget planners to quickly and effectively estimate distribution costs for country roadmaps. This model is presented in a separate document.
This report achieved four objectives: (1) allow accurate costing for the delivery of malaria commodities to the end user, (2) allow accurate planning and budgeting, (3) provide realistic estimates of distribution costs for inclusion in roadmaps and proposals, and (4) inform policy discussion by improving the accuracy of costing for ACT and RDT supply chains.
In this issue:
- Enhancing the Capacity of Namibia’s CMS Staff in Pharmaceutical Warehousing and Distribution
- Improving OVC Service Delivery by Building the Capacity of CSOs: CAFO’s Experience
- Assuring Safety of Antiretroviral Medicines Through Sentinel-based Pharmacovigilance in Namibia
- Creating Medicines Inventory Management Champions to Support Decentralization of Antiretroviral Treatment Services in Namibia
- Namibia’s National Health Training Center Develops a Manual for Sustaining the Quality of Pharmacy Assistants’ Training
- SCMS Contributes to Improved Availability of Antiretroviral Medicines in Namibia
- Utilizing Dispensing Data in Making Decisions on Improving the Quality of Service Delivery at Antiretroviral Therapy Sites in Namibia
A presentation by Kwesi Eghan, Principal Technical Advisor, on March 19, 2018.
According to the World Health Organization, many countries spend 30–40% of their health care budgets on medicines and medical commodities, […]
In Bangladesh, the Ministry’s Procurement and Logistics Management Cell (PLMC) made an assessment of the status of medical equipment that […]